MATINAS BIOPHARMA HOLDINGS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $33.1M | $22.2M |
| FY2020 | — | $63.7M | $12.4M |
| FY2021 | — | $52.5M | $21.0M |
| FY2022 | — | $36.6M | $6.8M |
| FY2023 | — | $19.2M | $4.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $33.1M | $22.2M |
| FY2020 | — | $63.7M | $12.4M |
| FY2021 | — | $52.5M | $21.0M |
| FY2022 | — | $36.6M | $6.8M |
| FY2023 | — | $19.2M | $4.8M |